Assignee
PROTEIMAX BIOTECNOLOGIA LTDA
BR·2 granted patents·1 pending application·1 citations·filing 2013–2022
Top patents by PatentIndex Score
3 records- 0147US9796760B2Modified peptide, CB receptor ligand, kit in vitro process for evaluating CB receptor bonds, uses, pharmaceutical composition for modulating CB receptor activityPROTEIMAX BIOTECNOLOGIA LTDA·Filed 2013·Granted Oct 24, 2017·1 cites·35 claims
- 0244US2024050514A1Use of compound, pharmaceutical composition for the treatment of immune or metabolic disorders, pharmaceutical composition for the treatment of illnesses caused by or associated with virusesPROTEIMAX BIOTECNOLOGIA LTDA·Filed 2022·Application pending·0 cites
- 0337US10933113B2Use of a compound, pharmaceutical composition, and therapeutic method for the treatment or prevention of convulsionsPROTEIMAX BIOTECNOLOGIA LTDA·Filed 2017·Granted Mar 2, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when PROTEIMAX BIOTECNOLOGIA LTDA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →